Showing results (651-660 of 914) with videos related to
Sort By:
Pageof 92
Biorxiv : the Preprint Server for Biology|September 25, 2023
WCRC-25: A novel luminal Invasive Lobular Carcinoma cell line modelAshuvinee Elangovan, Emily A Bossart, Ahmed Basudan, et al.Proceedings of the National Academy of Sciences of the United States of America|July 23, 2024
Spatial molecular profiling of mixed invasive ductal and lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.Biorxiv : the Preprint Server for Biology|June 25, 2024
Spatial molecular profiling of mixed invasive ductal-lobular breast cancers reveals heterogeneity in intrinsic molecular subtypes, oncogenic signatures, and mutationsOsama Shiraz Shah, Azadeh Nasrazadani, Julia Foldi, et al.Sexual Medicine|October 28, 2025
Preliminary psychometric linguistic validation of the satisfaction survey for inflatable penile implant in SpanishJose M Flores, Bernardita M Ljubetic, Luis F Novaes, et al.Journal of Pathology Informatics|May 20, 2021
Verification and Validation of Digital Pathology (Whole Slide Imaging) for Primary Histopathological Diagnosis: All Wales ExperienceM Babawale, A Gunavardhan, J Walker, et al.Clinical Trials (London, England)|December 1, 2020
Composite grading algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)Ethan Basch, Claus Becker, Lauren J Rogak, et al.Eclinicalmedicine|March 10, 2023
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort studyNeha Korde, Elizabet Tavitian, Donna Mastey, et al.Pediatric Diabetes|December 6, 2003
Aberrant monocyte prostaglandin synthase 2 (PGS2) expression in type 1 diabetes before and after disease onsetS A Litherland, J X She, D Schatz, et al.Cancer Cell|September 13, 2011
An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymomaJennifer M Atkinson, Anang A Shelat, Angel Montero Carcaboso, et al.Nature Communications|April 20, 2022
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activationZheqi Li, Olivia McGinn, Yang Wu, et al.Pageof 92